Table 5.
Yeast Tested | |||||
---|---|---|---|---|---|
C. albicans ATCC 10231 |
C. auris DSM 21092 |
C. tropicalis ATCC 7349 | C. glabrata ATCC 66032 | C. parapsilosis ATCC 22019 | |
Production of large areas of inhibition | |||||
CSP-CTS hydrogel | + (a) | R (b) | + | + | + |
CSP-P407 hydrogel | + | R | + | + | + |
CSP-CTS/P407 hydrogel | + | R | + | + | + |
Inhibition of fungi in situ where the sample has been deposited | |||||
CTS hydrogel | +r (c) | +r | + | + | + |
P407 hydrogel | + | + | + | + | − |
CTS/P407 hydrogel | +r | +r | + | + | + |
(a) +; formulation totally effective against the strain tested; − formulation does not produce any type of action on yeast growth. (b) R; There is a very marked inhibition effect on yeast growth at 24 h, but when incubating for longer up to 48 h, resistant growth appears within the first inhibition zone. (c) +, − o +r; Regarding the antifungal activity of the excipients at the point where the sample has been placed, whether they have inhibited growth, +, or not, −, or inhibit with resistant growth, +r.